Carderock Capital Management Inc. Trims Stake in Danaher Corporation $DHR

Carderock Capital Management Inc. lowered its position in Danaher Corporation (NYSE:DHR) by 95.7% in the 2nd quarter, Holdings Channel reports. The firm owned 1,106 shares of the conglomerate’s stock after selling 24,345 shares during the quarter. Carderock Capital Management Inc.’s holdings in Danaher were worth $211,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Bangor Savings Bank lifted its stake in shares of Danaher by 13.0% during the 2nd quarter. Bangor Savings Bank now owns 1,825 shares of the conglomerate’s stock worth $348,000 after acquiring an additional 210 shares during the last quarter. RDA Financial Network grew its position in Danaher by 12.9% in the 2nd quarter. RDA Financial Network now owns 2,423 shares of the conglomerate’s stock valued at $462,000 after acquiring an additional 276 shares during the last quarter. Boltwood Capital Management increased its stake in Danaher by 1.6% in the second quarter. Boltwood Capital Management now owns 4,440 shares of the conglomerate’s stock worth $846,000 after purchasing an additional 70 shares during the period. MassMutual Private Wealth & Trust FSB increased its stake in Danaher by 1.4% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 46,499 shares of the conglomerate’s stock worth $8,857,000 after purchasing an additional 660 shares during the period. Finally, CX Institutional lifted its position in shares of Danaher by 21.4% during the second quarter. CX Institutional now owns 41,221 shares of the conglomerate’s stock worth $7,852,000 after purchasing an additional 7,279 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 1.2%

NYSE:DHR opened at $195.04 on Wednesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a 50-day moving average of $189.32 and a 200 day moving average of $194.78. The firm has a market cap of $137.11 billion, a PE ratio of 34.64, a price-to-earnings-growth ratio of 2.46 and a beta of 0.78.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.77 EPS. As a group, research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on DHR. Guggenheim cut their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Argus decreased their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. Citigroup initiated coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. Rothschild & Co Redburn set a $205.00 target price on shares of Danaher in a research report on Friday, April 17th. Finally, DZ Bank assumed coverage on shares of Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.